Influential doctors aren’t disclosing their drug company ties

Two-thirds of all Australian guidelines lack transparency, suggests new study
Dr Ray Moynihan (PhD) Professor Lisa Bero

In September, the New York Times revealed that one of the world’s top cancer specialists had quietly received millions of dollars from drug and other companies. And what’s more, he’d failed to disclose the payments in many of his high-profile medical journal articles.

A few months before that, a study found that many experts who write medical textbooks received company payments, but again, their readers didn’t know about it.